SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001213900-20-037922
Filing Date
2020-11-18
Accepted
2020-11-18 13:53:36
Documents
1
Group Members
ALPHA BIOLABS, INC.

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO.7 TO SCHEDULE 13D ea130143sc13da7alpha_oncosec.htm SC 13D/A 36211
  Complete submission text file 0001213900-20-037922.txt   37745
Mailing Address 24 N. MAIN STREET PENNINGTON NJ 08534
Business Address 24 N. MAIN STREET PENNINGTON NJ 08534 (858) 210-7333
ONCOSEC MEDICAL Inc (Subject) CIK: 0001444307 (see all company filings)

IRS No.: 980573252 | State of Incorp.: NV | Fiscal Year End: 0731
Type: SC 13D/A | Act: 34 | File No.: 005-86770 | Film No.: 201324088
SIC: 2834 Pharmaceutical Preparations

Mailing Address GANGNAM-GU APGUJEONG-RO 62-GIL 17-10 SEOUL M5 06016
Business Address GANGNAM-GU APGUJEONG-RO 62-GIL 17-10 SEOUL M5 06016 011-8225178841
Alpha Holdings, Inc. (Filed by) CIK: 0001755469 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A